Pentoxifylline Downregulates ICAM-1 in Monocytes
2026-08-12
The 1997 reference study showed that Pentoxifylline reduces ICAM-1 expression in human monocytes at both the protein and mRNA levels after oral exposure in healthy volunteers and after direct in vitro treatment. Its TNF-α reversal and neutralization experiments connected this effect to suppression of TNF-α signaling, providing a mechanistic basis for studying this phosphodiesterase inhibitor as an anti-inflammatory compound.
WP1066: JAK2/STAT3 Inhibitor Workflows
2026-08-12
WP1066 provides a cell-permeable way to test JAK2/STAT3 dependence in cancer-cell proliferation, AML models, and renal carcinoma systems. This workflow guide also explains how to use the inhibitor as a mechanistic control when studying regenerative scaffolds that require, rather than suppress, JAK2-STAT3 signaling.
Sulfur Supply Delays Soybean Nodule Senescence
2026-08-11
This study identifies sulfur delivery into the soybean symbiosome as a regulatory bottleneck in nodule longevity. Genetic evidence links SULTR-mediated sulfur transport to glutathione maintenance and reactive nitrogen species control, suggesting strategies to preserve symbiotic nitrogen fixation under high-nitrogen stress.
Patient-Derived Gastric Cancer Assembloid Insights
2026-08-10
Shapira-Netanelov and colleagues developed gastric cancer assembloids that combine patient-matched tumor organoids with separately expanded stromal cell subpopulations. The model reproduced tumor-associated heterogeneity, altered transcriptomic states and drug responses relative to organoid monocultures, providing a more informative framework for studying resistance and individualized treatment strategies.
Staurosporine Workflows for Kinase and Cancer Research
2026-08-09
Staurosporine combines strong apoptosis-inducing activity with broad kinase pathway coverage, making it useful for viability, signaling, motility, and angiogenesis experiments. This guide emphasizes controlled DMSO handling, orthogonal readouts, and safeguards against mistaking cytotoxicity for pathway-specific inhibition.
CHIR 99021 Trihydrochloride: GSK-3 Workflows
2026-08-08
CHIR 99021 trihydrochloride provides a tunable GSK-3 inhibition strategy for organoid expansion, stem cell fate studies, and metabolic research. This guide translates recent intestinal organoid findings into practical dosing, assay design, and troubleshooting decisions while separating evidence-backed specifications from workflow recommendations.
Shenqi Fuzheng Injection in Glioma: SRC/PI3K/AKT
2026-08-07
This 2024 Journal of Ethnopharmacology study combines network pharmacology with cellular and mouse experiments to investigate how Shenqi Fuzheng injection affects glioma proliferation and migration. Its central contribution is the identification of SRC/PI3K/AKT signaling as a mechanistic axis associated with SFI-mediated cell-cycle arrest, reduced migration, and slower tumor growth.
FITC Goat Anti-Rabbit IgG (H+L) Antibody: Precision in Bioma
2026-08-07
Unlock next-level sensitivity in immunofluorescence with the FITC Goat Anti-Rabbit IgG (H+L) Antibody. Learn how tailored workflows and troubleshooting strategies can drive robust, reproducible biomarker discovery—especially in challenging applications like early diabetic nephropathy monitoring.
Leveraging WP1066, a JAK2/STAT3 Inhibitor, in Regeneration &
2026-08-06
WP1066, a cell-permeable JAK2/STAT3 inhibitor from APExBIO, enables precision dissection and modulation of the JAK2/STAT3 axis in both cancer and regenerative models. This article provides actionable workflows, protocol parameters, and troubleshooting insights to maximize reproducibility and translational relevance.
PARP1/FAK/COL5A1 Axis Drives EMT in Cholesterol-Resistant Ov
2026-08-06
This study uncovers how persistent high cholesterol promotes ovarian cancer progression by activating the PARP1/FAK/COL5A1 signaling pathway, leading to enhanced epithelial-mesenchymal transition (EMT). The work establishes cholesterol-resistant ovarian cancer cell models and provides mechanistic insights into tumor adaptation and potential therapeutic targets for drug-resistant disease.
JSH-23: Precision NF-κB Inhibitor Workflows for Inflammation
2026-08-05
JSH-23 enables targeted, reproducible inhibition of NF-κB transcriptional activity, supporting high-confidence workflows in both cell and animal models. This guide synthesizes the latest experimental insights, protocol refinements, and troubleshooting strategies to accelerate inflammation research and clarify NF-κB pathway contributions.
Quercetin Mitigates Cataract via Hippo Pathway Modulation in
2026-08-05
This study establishes quercetin’s ability to protect against cataract formation in a UVB-induced mouse model by suppressing the Hippo signaling pathway. The findings demonstrate a mechanistic link between Hippo pathway inactivation, improved oxidative stress profiles, and enhanced lens epithelial cell survival, suggesting new avenues for non-surgical cataract intervention.
Flavopiridol (A3417): Reliable CDK Inhibition for Cell Cycle
2026-08-04
This article delivers a scenario-driven, evidence-based exploration of Flavopiridol (SKU A3417) for cell viability, proliferation, and cytotoxicity assays. It addresses practical experimental challenges, provides data-backed guidance for protocol optimization, and compares vendor reliability, ensuring biomedical researchers achieve reproducible results with this pan-CDK inhibitor.
AZD-3463: Structural Precision and Pathway Selectivity in AL
2026-08-04
Explore how AZD3463, a leading ALK/IGF1R inhibitor, sets new standards in neuroblastoma research through structural selectivity and advanced pathway modulation. This article offers a uniquely detailed assay-design perspective, integrating structural insights and practical protocol guidance.
Oleanolic Acid Triggers Liver Injury via FXR Pathway Disrupt
2026-08-03
This study reveals that oleanolic acid (OA) induces hepatic injury by impairing hepatocyte tight junctions and dysregulating FXR-mediated bile acid efflux transporters, specifically BSEP and MRP2. The findings clarify the mechanistic link between OA exposure, tight junction integrity, and bile acid transporter function, providing new avenues for investigating FXR’s protective roles in liver physiology.
508 records 12/34 page Previous Next First page 上5页 1112131415 下5页 Last page